Delphine Le Corre

<i>KRAS</i> Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

Astrid Lièvre, Jean‐Baptiste Bachet, Delphine Le Corre et al. · Cancer Research · 2006 · 2.2K citations

Medicine, Oncology, Pharmacology +17

<i>KRAS</i> Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

Astrid Lièvre, Jean‐Baptiste Bachet, Valérie Boige et al. · Journal of Clinical Oncology · 2008 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Quantitative and sensitive detection of rare mutations using droplet-based microfluidics

Deniz Pekin, Yousr Skhiri, Jean‐Christophe Baret et al. · Lab on a Chip · 2011 · 525 citations

Medicine, Genetics, Oncology +17

Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients

Valérie Taly, Deniz Pekin, Léonor Benhaïm et al. · Clinical Chemistry · 2013 · 494 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

Valérie Boige, Jean Mendiboure, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2010 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17